trial · primary record
Cobimetinib
Chronic Myelomonocytic Leukemia (CMML)
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 14 |
| Primary completion | 2026-10 |
| Primary endpoint | Overall Response Rate (ORR) |
| Registry ID | NCT04409639 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:45.244Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04409639
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.